Home LiteratureArticle Details
PMID: 10691297 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia.

Journal of molecular neuroscience : MN ·Vol. 13 ·No. 1-2 ·1999-00-00 ·Pages 101-9

Blennow K, Bogdanovic N, Gottfries CG, Davidsson P

Abstract

Schizophrenia is a common and severe psychiatric disorder of unknown etiology. Numerous neuropathological studies have found subtle structural changes in limbic structures, especially medial temporal lobe structures and the gyrus cinguli. To test the hypothesis that synaptic disturbances are involved in the pathogenesis of schizophrenia, we studied the growth-associated protein 43 (GAP-43), a protein localized to presynaptic terminals, suggested to be involved in establishment and remodeling of synaptic connections, in postmortem brain tissue, using quantitative Western blotting immunohistochemistry. The material consisted of brain tissue from 17 schizophrenics (80 +/- 11 yr), diagnosed according to the DSM-III-R criteria, and 20 age-matched controls (75 +/- 13 yr). Quantitative analyses showed increased GAP-43 protein levels in schizophrenic compared to control brains, both in the hippocampus (2.43 +/- 0.78 vs 1.00 +/- 0.29; p < 0.0001) and in the gyrus cinguli (1.52 +/- 0.21 vs 1.00 +/- 0.35; p < 0.0001). Also by immunohistochemistry, increased GAP-43 staining was found in schizophrenic compared with control brains, throughout all layers of the gyrus cinguli and the hippocampus. Anomalous synaptic sprouting and reorganization, with resultant "miswiring," as well as a defect in synaptic pruning have been hypothesized to be pathogenetic factors in schizophrenia. We suggest that a decreased synaptic density, whether caused by disturbed development or damage/degeneration, may elicit a reactive synaptogenesis (reflected by an increase in GAP-43), which may be functional or anomalous. Synaptic pathology in the limbic system may be of importance in the development of psychotic symptoms in schizophrenia.

MeSH Terms
Aged Aged, 80 and over Female GAP-43 Protein/metabolism Gyrus Cinguli/metabolism Hippocampus/metabolism Humans Immunohistochemistry Male Schizophrenia/metabolism
Chemicals
GAP-43 Protein
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Blennow K
Göteborg University, Institute of Clinical Neuroscience, Department of Psychiatry and Neurochemistry, Sahlgren's University Hospital, Mölndal, Sweden.
Bogdanovic N
Gottfries C G
Davidsson P
References (42)
42 references, click to expand
  1. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
    Ann Neurol. 1991 Oct;30(4):572-80 PMID: 1789684
  2. Cell loss in the hippocampus of schizophrenics.
    Eur Arch Psychiatry Neurol Sci. 1986;236(3):154-61 PMID: 3803399
  3. GAP-43: an intrinsic determinant of neuronal development and plasticity.
    Trends Neurosci. 1997 Feb;20(2):84-91 PMID: 9023877
  4. GAP-43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system.
    Brain Res Dev Brain Res. 1989 Apr 1;46(2):161-8 PMID: 2720952
  5. Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients.
    Acta Psychiatr Scand. 1981 Mar;63(3):225-44 PMID: 6786003
  6. Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease.
    Biol Psychiatry. 1995 Jan 15;37(2):122-6 PMID: 7718676
  7. The pattern of GAP-43 immunostaining changes in the rat hippocampal formation during reactive synaptogenesis.
    Brain Res Mol Brain Res. 1990 Jun;8(1):17-23 PMID: 2166197
  8. Hippocampal pathologic findings in schizophrenia. A morphometric study.
    Arch Gen Psychiatry. 1989 Nov;46(11):1019-24 PMID: 2818139
  9. From neuropathology to neurodevelopment.
    Lancet. 1995 Aug 26;346(8974):552-7 PMID: 7544856
  10. Specific changes in rapidly transported proteins during regeneration of the goldfish optic nerve.
    J Neurosci. 1981 Mar;1(3):300-7 PMID: 6167694
  11. Compensatory mechanisms in an attractor neural network model of schizophrenia.
    Neural Comput. 1995 Jan;7(1):182-205 PMID: 8936058
  12. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions.
    Am J Psychiatry. 1995 May;152(5):738-48 PMID: 7726314
  13. Neuroimaging in schizophrenia research.
    Schizophr Bull. 1993;19(2):337-53 PMID: 8322037
  14. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.
    Arch Gen Psychiatry. 1991 Nov;48(11):996-1001 PMID: 1747023
  15. Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle.
    J Neurobiol. 1992 Apr;23(3):309-21 PMID: 1385623
  16. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method.
    Mol Chem Neuropathol. 1995 Jan;24(1):1-11 PMID: 7755843
  17. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.
    Arch Gen Psychiatry. 1995 Oct;52(10):805-18; discussion 819-20 PMID: 7575100
  18. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.
    Neuroscience. 1995 Nov;69(2):339-43 PMID: 8552231
  19. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.
    Arch Gen Psychiatry. 1986 Jan;43(1):31-5 PMID: 3942472
  20. Post-mortem study of chronic schizophrenic brains.
    Br J Psychiatry. 1987 Dec;151:744-52 PMID: 3502800
  21. Synaptic degeneration in thalamus in schizophrenia.
    Lancet. 1996 Sep 7;348(9028):692-3 PMID: 8782788
  22. Visual experience regulates gene expression in the developing striate cortex.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4781-4 PMID: 2543986
  23. [Synaptogenesis and synaptic pruning: role in triggering schizophrenia].
    Presse Med. 1996 Nov 2;25(33):1595-8 PMID: 8952675
  24. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Arch Gen Psychiatry. 1997 Jul;54(7):660-9 PMID: 9236550
  25. Synthesis and transport of GAP-43 in entorhinal cortex neurons and perforant pathway during lesion-induced sprouting and reactive synaptogenesis.
    Brain Res Mol Brain Res. 1992 Jun;14(1-2):147-53 PMID: 1379667
  26. Primary structure and transcriptional regulation of GAP-43, a protein associated with nerve growth.
    Cell. 1987 Jun 19;49(6):785-91 PMID: 3581170
  27. Reduced neuronal size in posterior hippocampus of schizophrenic patients.
    Schizophr Bull. 1991;17(4):597-608 PMID: 1805353
  28. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.
    Nature. 1995 Nov 9;378(6553):180-2 PMID: 7477319
  29. Neurobiological investigations in cingulate cortex of schizophrenic brain.
    Schizophr Bull. 1993;19(3):537-49 PMID: 8235456
  30. Abnormal reinnervation as a basis for schizophrenia: a hypothesis.
    Arch Gen Psychiatry. 1992 Mar;49(3):238-43 PMID: 1567277
  31. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14182-7 PMID: 8943081
  32. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
    J Neural Transm (Vienna). 1996;103(5):603-18 PMID: 8811505
  33. Cingulate gyrus in schizophrenic patients and normal volunteers.
    Psychiatry Res. 1995 Nov 10;61(4):201-8 PMID: 8748465
  34. Synaptogenesis in the rat suprachiasmatic nucleus demonstrated by electron microscopy and synapsin I immunoreactivity.
    J Neurosci. 1989 Jun;9(6):2151-62 PMID: 2498469
  35. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  36. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?
    Mol Chem Neuropathol. 1996 Feb;27(2):195-210 PMID: 8962603
  37. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones.
    Proc Natl Acad Sci U S A. 1986 May;83(10):3537-41 PMID: 3517863
  38. Glutamate receptor dysfunction and schizophrenia.
    Arch Gen Psychiatry. 1995 Dec;52(12):998-1007 PMID: 7492260
  39. Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells.
    J Cell Biol. 1981 Apr;89(1):86-95 PMID: 6164682
  40. Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex.
    J Neurosci. 1989 Mar;9(3):990-5 PMID: 2466968
  41. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10850-4 PMID: 1961755
  42. Recent advances in the neuropathology of schizophrenia.
    Schizophr Bull. 1993;19(2):431-45 PMID: 8322039
Article Info
Journal
Journal of molecular neuroscience : MN
Abbr.
J Mol Neurosci
ISSN
0895-8696
Published
1999-00-00
Pages
101-9
Language
English
Region
United States
NLM ID
9002991
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]